英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Galantide |
多克隆抗體 |
138579-66-5 |
詳細(xì)
|
R-F-NH2 |
H-ARG-PHE-NH2 |
119051-99-9 |
詳細(xì)
|
Fmoc-Ala-Ala-OH |
FMOC-丙氨酰丙氨酸 |
87512-31-0 |
詳細(xì)
|
Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro-Ala) |
環(huán)-(-GLY-ARG-GLY-ASP-SER-PRO-ALA) |
128857-77-2 |
詳細(xì)
|
Eptifibatide |
依替巴肽 |
188627-80-7 |
詳細(xì)
|
Fibronectin Fragment (1376-1380) |
FIBRONECTIN FRAGMENT (1376-1380) |
158622-13-0 |
詳細(xì)
|
2-Adamantanecarbonyl-Arg-Phe-NH2 |
2-Adamantanecarbonyl-Arg-Phe-NH trifluoroacetate salt |
1053615-07-8 |
詳細(xì)
|
RGD-targeted Proapoptotic Peptide |
606439 |
2243207-09-0 |
詳細(xì)
|
H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH |
GRGDSPK |
111119-28-9 |
詳細(xì)
|
(D-Thr6,D-Trp8.9,L-alaninol15)-Galanin (1-15) |
(D-THR6,D-TRP8·9,L-ALANINOL15)-GALANIN (1-15) |
150940-97-9 |
詳細(xì)
|
c(RGDfE) |
cyclo (Arg-Gly-Asp-d-Phe-Glu) |
756500-22-8 |
詳細(xì)
|
Integrin Binding Peptide |
衍生自纖連蛋白多肽 |
278792-07-7 |
詳細(xì)
|
FITC-εAhx-Gly-Arg-Gly-Asp-Ser-Pro-OH |
FITC-εAhx-Gly-Arg-Gly-Asp-Ser-Pro-OH |
2022956-44-9 |
詳細(xì)
|
Galanin (1-13)-Neuropeptide Y (25-36), amide (M32) |
Galanin (1-13)-Neuropeptide Y (25-36) amide |
147138-51-0 |
詳細(xì)
|
H-Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys-OH (Disulfide bond) |
H-CYS-ARG-GLY-ASP-PHE-PRO-ALA-SER-SER-CYS-OH |
166184-23-2 |
詳細(xì)
|
Alarin (human) |
Alarin (human) |
909409-86-5 |
詳細(xì)
|
Galacto-RGD |
GALACTO-RGD |
922175-70-0 |
詳細(xì)
|
c(RGDfC) |
CYCLO (ARG-GLY-ASP-D-PHE-CYS) |
862772-11-0 |
詳細(xì)
|
Fibronectin Analog |
GLY-ARG-ALA-ASP-SER-PRO-LYS |
125455-58-5 |
詳細(xì)
|
Fmoc-Nle-Nle-OH |
FMOC-NLE-NLE-OH |
251316-91-3 |
詳細(xì)
|
H-Gly-Pen-Gly-Arg-Gly-Asp-Ser-Pro-Cys-Ala-OH (Disulfide bond between Pen2 and Cys9) |
H-GLY-PEN-GLY-ARG-GLY-ASP-SER-PRO-CYS-ALA-OH |
126716-28-7 |
詳細(xì)
|
Fmoc-Gly-Pro-Hyp-OH |
FMOC-GLY-PRO-HYP-OH |
185213-75-6 |
詳細(xì)
|
FMRF-related peptide |
GLP-ASP-PRO-PHE-LEU-ARG-PHE-NH2: GLP-DPFLRF-NH2 |
98495-35-3 |
詳細(xì)
|
Galanin, Porcine |
神經(jīng)節(jié)肽(抗原) |
88813-36-9 |
詳細(xì)
|
M35 |
GALANIN (1-13) - BRADYKININ (2-9) AMIDE |
142846-71-7 |
詳細(xì)
|
H-Gly-Phe-Arg-Gly-Asp-Gly-Gln-OH |
H-GLY-PHE-ARG-GLY-ASP-GLY-GLN-OH |
148913-98-8 |
詳細(xì)
|
H-Gly-Arg-Gly-Asp-Ser-Cys-OH |
H-GLY-ARG-GLY-ASP-SER-CYS-OH |
91037-71-7 |
詳細(xì)
|
(Ala6,D-Trp8,L-alaninol15)-Galanin (1-15) |
(ALA6,D-TRP8,L-ALANINOL15)-GALANIN (1-15) |
184683-37-2 |
詳細(xì)
|
H-Asp-Arg-Gly-Asp-Ser-OH |
H-ASP-ARG-GLY-ASP-SER-OH |
151997-53-4 |
詳細(xì)
|
H-Arg-Gly-Asp-Ser-Pro-OH |
H-ARG-GLY-ASP-SER-PRO-OH TRIFLUOROACETATE SALT |
110697-44-4 |
詳細(xì)
|
GRGDSPC |
H-GLY-ARG-GLY-ASP-SER-PRO-CYS-OH |
91575-26-7 |
詳細(xì)
|
Cyclo(-Arg-Ala-Asp-D-Tyr-Lys) |
cyclo (Arg-Ala-Asp-Tyr-Lys) |
1193347-53-3 |
詳細(xì)
|
Fibronectin Adhesion-Promoting Peptide |
FIBRONECTIN ADHESION-PROMOTING PEPTIDE |
125720-21-0 |
詳細(xì)
|
RGD-4C |
ALA-CYS-ASP-CYS-ARG-GLY-ASP-CYS-PHE-CYS-GLY(DISULFIDE BRIDGE:CYS2-CYS10, CYS4-CYS8) |
332179-76-7 |
詳細(xì)
|
Arg-Gly-Glu-Ser |
H-ARG-GLY-GLU-SER-OH |
93674-97-6 |
詳細(xì)
|
(D-His1)-Exenatide |
(D-HIS1)-EXENATIDE TRIFLUOROACETATE SALT |
1678417-09-8 |
詳細(xì)
|
Echistatin, α1 isoform |
ECHISTATIN |
154303-05-6 |
詳細(xì)
|
Fmoc-Phe-Arg-OH |
FMOC-PHE-ARG-OH |
250695-64-8 |
詳細(xì)
|
K-G-D-S |
H-LYS-GLY-ASP-SER-OH |
93674-95-4 |
詳細(xì)
|
H-Pro-Ser-Hyp-Gly-Asp-Trp-OH |
H-PRO-SER-HYP-GLY-ASP-TRP-OH |
163722-91-6 |
詳細(xì)
|
Cyclo(RADfK) |
整合素配體多肽Cyclo(Arg-Ala-Asp-d-Phe-Lys) |
756500-23-9 |
詳細(xì)
|
Gly-Arg-Gly-Asp-Ser |
GLY-ARG-GLY-ASP-SER |
96426-21-0 |
詳細(xì)
|
Fibronectin Fragment (196-203) |
FIBRONECTIN FRAGMENT (196-203) |
150525-72-7 |
詳細(xì)
|
Arg-Gly-Asp-Cys |
Arg-Gly-Asp-Cys |
109292-46-8 |
詳細(xì)
|
R-G-D-S-P-A-S-S-K-P |
H-ARG-GLY-ASP-SER-PRO-ALA-SER-SER-LYS-PRO-OH |
91575-25-6 |
詳細(xì)
|
H-Gly-Arg-Gly-Asp-OH |
GLY-ARG-GLY-ASP |
97461-81-9 |
詳細(xì)
|
Fibrinopeptide A, human |
血纖維蛋白肽A(人) |
25422-31-5 |
詳細(xì)
|
Fmoc-Phe-Phe-OH |
FMOC-PHE-PHE-OH |
84889-09-8 |
詳細(xì)
|
H-Gly-Arg-Gly-Asp-Asn-Pro-OH |
H-甘氨酰-精氨酰-甘氨酰-天冬氨酰-天冬酰胺酰-脯氨酸-OH |
114681-65-1 |
詳細(xì)
|
Biotinyl-εAhx-Gly-Arg-Gly-Asp-Ser-OH |
BIOTINYL-ΕAHX-GLY-ARG-GLY-ASP-SER-OH TRIFLUOROACETATE SALT |
2022956-45-0 |
詳細(xì)
|
Exendin-4 (1-8) |
Exendin-4 (1-8) |
1802078-29-0 |
詳細(xì)
|
(4-((2-Methylphenyl)aminocarbonyl)-aminophenyl)acetyl-Fibronectin CS-1 Fragment (1980-1983) |
化合物BIO-1211 |
187735-94-0 |
詳細(xì)
|
Fmoc-Gly-Gly-Gly-OH |
FMOC-GLY-GLY-GLY-OH |
170941-79-4 |
詳細(xì)
|
Tyr0] Fibrinopeptide A, human |
(TYR0)-FIBRINOPEPTIDE A |
103226-11-5 |
詳細(xì)
|
(Glu9)-Exenatide (2-39) |
(GLU9)-艾塞那肽(2-39) |
196109-34-9 |
詳細(xì)
|
Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) |
CYCLO(-GLY-ARG-GLY-ASP-SER-PRO) |
135432-37-0 |
詳細(xì)
|
Fmoc-Gly-Val-OH |
FMOC-GLY-VAL-OH |
86895-14-9 |
詳細(xì)
|
Cilengitide |
西侖吉肽 |
188968-51-6 |
詳細(xì)
|
Helodormin |
HELODERMIN |
89468-62-2 |
詳細(xì)
|
G-R-G-D-T-P |
GLY-ARG-GLY-ASP-THR-PRO |
108682-58-2 |
詳細(xì)
|
c(RGDyK) |
CYCLO (RGDYK) |
217099-14-4 |
詳細(xì)
|
H-Gly-Arg-Gly-Glu-Ser-OH |
GLY-ARG-GLY-GLU-SER |
97461-84-2 |
詳細(xì)
|
Met(O)14-Exenatide |
[MET(O)14]-EXENATIDE |
1678417-38-3 |
詳細(xì)
|
H-Gly-Arg-Gly-Asp-Ser-NH2 |
GRGDS, AMIDE |
143648-02-6 |
詳細(xì)
|
Arg-Gly-Asp-Ser |
Arg-Gly-Asp-Ser |
91037-65-9 |
詳細(xì)
|
H-D-Arg-Gly-Asp-Trp-OH |
arginyl-glycyl-aspartyl-tryptophan |
144161-76-2 |
詳細(xì)
|
Fmoc-Pro-Pro-Pro-OH |
FMOC-PRO-PRO-PRO-OH |
134303-96-1 |
詳細(xì)
|
Collagen Binding Fragment |
CYS-GLN-ASP-SER-GLU-THR-ARG-THR-PHE-TYR |
94040-53-6 |
詳細(xì)
|
H-Gly-Arg-Ala-Asp-Ser-Pro-OH |
GLY-ARG-ALA-ASP-SER-PRO |
99896-86-3 |
詳細(xì)
|
Cyclo(-Gly-Arg-Gly-Glu-Ser-Pro) |
Cyclo(-Gly-Arg-Gly-Glu-Ser-Pro) |
2022956-43-8 |
詳細(xì)
|
Fmoc-Phe-Ser(tBu)-OH |
FMOC-PHE-SER(TBU)-OH |
157675-78-0 |
詳細(xì)
|
E-[c(RGDfK)2] |
E[c(RGDfK)]c(RGDfK) |
250612-47-6 |
詳細(xì)
|
RFDS |
ARG-PHE-ASP-SER |
102567-19-1 |
詳細(xì)
|
RGD Negative Control |
RGD NEGATIVE CONTROL TRIFLUOROACETATE SALT |
756500-24-0 |
詳細(xì)
|
Y-R-G-D-S |
H-TYR-ARG-GLY-ASP-SER-OH |
134282-68-1 |
詳細(xì)
|
H-Lys-Gly-Glu-OH |
H-LYS-GLY-GLU-OH |
88096-12-2 |
詳細(xì)
|
Fibronectin Fragment (1377-1388) |
FIBRONECTIN FRAGMENT (1377-1388) |
162257-99-0 |
詳細(xì)
|
Neuropeptide SF (human) |
NEUROPEPTIDE SF (HUMAN) |
192387-39-6 |
詳細(xì)
|
RGDV |
H-ARG-GLY-ASP-VAL-OH |
93674-99-8 |
詳細(xì)
|
Fibrinopeptide B, human |
血纖維蛋白肽B(人) |
36204-23-6 |
詳細(xì)
|
Fibronectin Fragment (1954-1959) |
FIBRONECTIN FRAGMENT (1954-1959) |
184895-13-4 |
詳細(xì)
|
Cyclo(-Arg-Ala-Asp-D-Phe-Val) |
C(RADfV) |
137813-36-6 |
詳細(xì)
|
H-Gly-Arg-Gly-Asp-D-Ser-Pro-OH |
GLY-ARG-GLY-ASP-DSER-PRO |
111844-24-7 |
詳細(xì)
|
Fibronectin CS-1 Peptide |
FIBRONECTIN CS-1 FRAGMENT (1978-1985) |
136466-51-8 |
詳細(xì)
|
RFRP-3 (rat) |
RFRP-2 (RAT) |
420088-80-8 |
詳細(xì)
|
26Rfa,Hypothalamic Peptide,rat |
ORPHAN GPCR SP9155 AGONIST P550 (MOUSE) |
600171-70-8 |
詳細(xì)
|
Bifunctional Antiplatelet Agent |
BIFUNCTIONAL ANTIPLATELET AGENT |
148796-92-3 |
詳細(xì)
|
Phenylac-Leu-Asp-Phe-D-Pro-NH2 |
|
209601-16-1 |
詳細(xì)
|
Fmoc-Pro-Phe-OH |
FMOC-PRO-PHE-OH |
120943-07-9 |
詳細(xì)
|
AF-2 |
AF2 neuropeptide |
146269-94-5 |
詳細(xì)
|
c(RGDfV) |
環(huán)(ARG-GLS-ASP-D-PHE-VAL) |
137813-35-5 |
詳細(xì)
|
Cyclo(-Ala-Arg-Gly-Asp-3-aminomethylbenzoyl) |
CYCLO(-ALA-ARG-GLY-ASP-3-AMINOMETHYLBENZOYL) |
153381-95-4 |
詳細(xì)
|
H-Lys-Gln-Ala-Gly-Asp-Val-OH |
H-LYS-GLN-ALA-GLY-ASP-VAL-OH |
80755-87-9 |
詳細(xì)
|
H-Ser-Asp-Gly-Arg-Gly-OH |
H-SER-ASP-GLY-ARG-GLY-OH |
108608-63-5 |
詳細(xì)
|
H-Gly-Arg-Gly-Glu-Ser-Pro-OH |
glycyl-arginyl-glycyl-glutamyl-seryl-proline |
99896-88-5 |
詳細(xì)
|
H-Phe-Leu-Arg-Phe-NH2 |
phenylalanyl-leucyl-arginyl phenylalaninamide |
80690-77-3 |
詳細(xì)
|
Fmoc-Pro-Pro-Pro-Pro-OH |
FMOC-PRO-PRO-PRO-PRO-OH |
454693-96-0 |
詳細(xì)
|
GRGDSP TFA |
GRGDSP |
91037-75-1 |
詳細(xì)
|
E-I-L-D-V, human, bovine, rat |
GLU-ILE-LEU-ASP-VAL |
150525-67-0 |
詳細(xì)
|
Cyclo(-D-Tyr-Arg-Gly-Asp-Cys(carboxymethyl)-OH) |
CYCLO(-D-TYR-ARG-GLY-ASP-CYS(CARBOXYMETHYL)-OH) SULFOXIDE |
143120-27-8 |
詳細(xì)
|